Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
140 hedge funds and large institutions have $1.13B invested in Immunogen Inc in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 23 closing their positions.
85% more call options, than puts
Call options by funds: $6.99M | Put options by funds: $3.78M
70% more capital invested
Capital invested by funds: $665M → $1.13B (+$467M)
2% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 44
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
1% less funds holding
Funds holding: 141 → 140 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$33.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$18.1M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$14.5M |
| 4 |
O
OrbiMed
New York
|
+$11.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$9.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$25.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$10.6M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$3.33M |
| 4 |
Barclays
London,
United Kingdom
|
-$3.19M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$3.16M |
IMGN Hedge Fund Activity: Q2 2015 in Review
140 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2015, worth a combined $1.13B — up 70% from $665M a quarter earlier.
Fund positioning in IMGN was balanced in Q2 2015: 23 funds opened new positions, 23 closed out, 45 added to existing stakes and 44 trimmed.
The largest buyer was Millennium Management, adding an estimated $33.3M. The largest seller was BB Biotech, exiting entirely with an estimated $25.4M sold.
- 140 institutional investors held Immunogen Inc (IMGN) as of Q2 2015, down from 141 in Q1 2015.
- Funds reported $1.13B of Immunogen Inc stock for Q2 2015, up 70% quarter-over-quarter.
- 23 funds opened new Immunogen Inc positions in Q2 2015 and 23 closed out, a net change of 0 holders.
- The largest Immunogen Inc buyer in Q2 2015 was Millennium Management, an estimated $33.3M added.
- The largest Immunogen Inc seller in Q2 2015 was BB Biotech, an estimated $25.4M sold.
Based on aggregated 13F filings for Q2 2015.